Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001628280-24-006433

Chief Financial Officer acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Byrne Jason Chief Financial Officer 2024-02-20 Grant or award +33,000 59,224 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Byrne Jason Chief Financial Officer 2024-02-20 Grant or award · Option to purchase Common Stock +153,000 153,000 D: show line 2 in the form
Loading xslF345X05/wk-form4_1708640897.xml…